Pathologic phosphorylation and subsequent aggregation of the microtubule binding protein tau (MAPT) is believed to play a central role in driving cognitive decline in Alzheimer's disease (AD) and related tauopathies. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.